Abstract:Objective To investigate the risk factors of kidney re-transplantation recipients and graft survival during the long-term follow-up. Methods The clinical data of kidney transplant donors and recipients performed at the Kidney Disease Center of the First Affiliated Hospital of Zhejiang University from January 1, 1991 to December 31, 2017 were retrospectively analyzed. A total of 5 374 cases of first kidney transplantation and 37 cases of re-transplantation were included. In addition, the recipients of re-transplantation were divided into long-term survival group (19 cases, >5 years) and short-term survival group (18 cases, ≤5 years). The age of donor and recipient, the interval between first and second kidney transplantation, HLA mismatch and cold/warm ischemia time of donor and recipient in long-term and short-term survival groups were compared by group t test. Chi-square test was used to compare the gender of recipients, type of donor kidney, rate of positive panel reactive antibodies before and after re-transplantation, initial graft nephrectomy, immune induction before re-transplantation, delayed graft function (DGF) and acute rejection in two groups. The 1, 5 and 10-year patient/graft survival rates were calculated by Kaplan-Meier method. The Cox proportional hazard model was used to analyze the possible risk factors on long-term survival of transplanted kidney. P<0.05 was statistically significant. Results As of March 1, 2018, the median follow-up time of re-transplantation group was 152 months (11-323 months), 2 recipients died, 18 reipients suffered from renal allograft dysfunction and 17 patients had stable renal transplant function. The median follow-up time of the first transplantation group was 108.9 months (0.1-350.0 months). 459 cases died and 1 343 cases suffered from renal transplant failure. The 1, 5 and 10-year recipient/graft survival rates in the re-transplantation group were 86%/81%, 86%/62% and 82%/36%, and the 1, 5 and 10-year recipient/graft survival rates in the first transplantation group were 99%/98%, 93%/89% and 88%/80%. The 1, 5 and 10-year recipients survival rates of re-transplantation group were lower than those in the first transplantation group (χ2= 60.816, 25.110 and 43.900, P<0.05), and the 1-year recipients survival rate in the re-transplantation group was lower than the first transplantation group (χ2= 40.409, P<0.05). Univariate analysis showed that there were significant differences in DGF and acute rejection rates between long-term and short-term survival groups (χ2=4.039 and 4.748, P<0.05). Cox regression analysis showed that DGF and acute rejection were independent risk factors for long-term survival of transplanted kidneys in re-transplanted recipients (RR=4.317 and 4.571, P<0.05). Conclusions The survival rate of re-transplant recipients is lower than that of the first renal transplant recipients. DGF and acute rejection are independent risk factors affecting the survival of re-transplant recipients. Key words: Kidney transplantation; Re-transplantation; Cox proportional hazard model; Acute rejection; Delayed graft function

Outcomes of Older Primary Kidney Transplant Recipients by Induction Agent and High-risk Viral Discordance Status in the United States

Outcomes of kidney transplantation in patients with IgA nephropathy based on induction: A UNOS data analysis

Impact of Clinical Condition at Restarting Dialysis on Outcome after Kidney Allograft Loss: a Single-Center Experience.

Clinical Presentations and Outcome Analysis of Renal Transplant in Elderly Patients——a Single Center Retrospective Study

Interleukin-2 Receptor Antagonist Compared With Antithymocyte Globulin Induction Therapy In Kidney Transplantation From Donors After Cardiac Death

Risk Factors of Kidney Re-Transplantation Recipients and Graft Survival During the Long-Term Follow-Up

Induction Immunosuppression Improves Long-Term Graft and Patient Outcome in Organ Transplantation: an Analysis of United Network for Organ Sharing Registry Data.

The impact of induction therapy on the risk of posttransplant lymphoproliferative disorder in adult kidney transplant recipients with donor-recipient serological Epstein-Barr virus mismatch

Impact of Renal Allograft Nephrectomy on Graft and Patient Survival Following Retransplantation: a Systematic Review and Meta-Analysis

Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation.

Long-term Effectiveness of Anti-Interleukin-2 Receptor Antibodies Vs.rabbit Antithymocyte Globulin As Induction Therapy in Kidney Transplantation

Immune Reconstitution and Survival of Patients after Allogeneic Hematopoietic Stem Cell Transplantation from Older Donors

Effect of Different Induction Therapies on the Clinical Outcomes of ABO-incompatible Living Donor Kidney Transplantation Recipients

Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era

Early clearance of BK polyomavirus-DNAemia among kidney transplant recipients may lead to better graft survival

Impact of induction agents and maintenance immunosuppression on torque teno virus loads and year-one complications after kidney transplantation

Outcomes of Induction Antibody Therapies in the Nonbroadly Sensitized Adult Deceased Donor Kidney Transplant Recipients: a Retrospective Cohort Registry Analysis

Association of BKV viremia and nephropathy with adverse alloimmune outcomes in kidney transplant recipients

Evolving trends in immunosuppression use and cytomegalovirus infection risk over the past decade in kidney transplantation

Factors Influencing Viral Clearance and Graft Outcomes Following Diagnosis of Polyomavirus Bk-Associated Nephropathy after Renal Transplantation.

Survival Advantage Comparing Older Living Donor Versus Standard Criteria Donor Kidney Transplants